104 related articles for article (PubMed ID: 12879604)
41. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
Eichler AF; Kuter I; Ryan P; Schapira L; Younger J; Henson JW
Cancer; 2008 Jun; 112(11):2359-67. PubMed ID: 18361426
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical visualisation of cathepsin-D expression in breast cancer.
Barthell E; Mylonas I; Shabani N; Kunze S; Kuhn C; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2035-9. PubMed ID: 17649818
[TBL] [Abstract][Full Text] [Related]
43. Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast.
Honma N; Saji S; Kurabayashi R; Aida J; Arai T; Horii R; Akiyama F; Iwase T; Harada N; Younes M; Toi M; Takubo K; Sakamoto G
APMIS; 2008 Oct; 116(10):923-30. PubMed ID: 19132986
[TBL] [Abstract][Full Text] [Related]
44. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
45. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
46. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
47. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.
Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA
Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611
[TBL] [Abstract][Full Text] [Related]
48. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
49. Bilateral breast cancer.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(1):49-54. PubMed ID: 12044060
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
51. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
Jang KS; Han HX; Paik SS; Brown PH; Kong G
Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
[TBL] [Abstract][Full Text] [Related]
53. Molecular markers of therapeutic resistance in breast cancer.
Zhou L; Luo Y; Li K; Tian L; Wang M; Li C; Huang Q
Hum Pathol; 2013 Jul; 44(7):1421-8. PubMed ID: 23434145
[TBL] [Abstract][Full Text] [Related]
54. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A
Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report.
Hartveit F
Oncol Rep; 1998; 5(2):423-6. PubMed ID: 9468572
[TBL] [Abstract][Full Text] [Related]
56. The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma.
Gamel JW; Meyer JS; Feuer E; Miller BA
Cancer; 1996 Apr; 77(8):1459-64. PubMed ID: 8608529
[TBL] [Abstract][Full Text] [Related]
57. [Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study].
Mezi S; Aloise G; Marzullo A; Marchei P; Di Benedetto A; Modica A; Vasaturo F; Modesti M
G Chir; 1997 May; 18(5):263-8. PubMed ID: 9312252
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic value of tumor cells in bone marrow in breast cancer].
Untch M; Nestle-Krämling C; Konecny G; Harbeck N; Funke I; Kimmig R; Hepp H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():308-10. PubMed ID: 8118327
[No Abstract] [Full Text] [Related]
59. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
Fritzsche FR; Thomas A; Winzer KJ; Beyer B; Dankof A; Bellach J; Dahl E; Dietel M; Kristiansen G
Histol Histopathol; 2007 Nov; 22(11):1221-30. PubMed ID: 17647195
[TBL] [Abstract][Full Text] [Related]
60. Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer.
Petricevic B; Vrbanec D; Jakic-Razumovic J; Brcic I; Rabic D; Badovinac T; Ozimec E; Bali V
Med Oncol; 2012 Jun; 29(2):486-94. PubMed ID: 21400218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
